UNIVER (UHS) Reports Strong 2025 Financial Results

By Chris Stiles • Thursday, February 26 12:04 • Permanent Link

Universal Health Services, Inc. (UHS) has announced its financial results for the three and twelve-month periods ended December 31, 2025, and provided an operating results forecast for the full year of 2026.

During the fourth quarter of 2025, UHS reported a net income attributable to UHS of $445.9 million, or $7.06 per diluted share, compared to $332.4 million, or $4.96 per diluted share, during the fourth quarter of 2024. Net revenues also increased by 9.1% to $4.486 billion during the fourth quarter of 2025, compared to $4.114 billion during the fourth quarter of 2024.

Adjusted net income attributable to UHS for the fourth quarter of 2025 was $371.4 million, or $5.88 per diluted share, compared to $329.9 million, or $4.92 per diluted share, during the fourth quarter of 2024.

For the full year of 2025, reported net income attributable to UHS was $1.489 billion, or $23.10 per diluted share, compared to $1.142 billion, or $16.82 per diluted share, during 2024. Net revenues increased by 9.7% to $17.365 billion during the full year of 2025, compared to $15.828 billion during 2024.

UHS's EBITDA net of NCI was $785.1 million during the fourth quarter of 2025, compared to $620.2 million during the fourth quarter of 2024. For the full year of 2025, EBITDA net of NCI was $2.725 billion, compared to $2.248 billion during 2024.

In terms of services, net revenues generated from UHS's acute care services on a same facility basis increased by 6.9% during the fourth quarter of 2025, compared to the fourth quarter of 2024. For the full year of 2025, net revenues from acute care services increased by 8.5% compared to 2024.

For behavioral health care services, net revenues generated on a same facility basis increased by 7.2% during the fourth quarter of 2025, compared to the fourth quarter of 2024. For the full year of 2025, net revenues from behavioral health care services increased by 7.7% compared to 2024.

UHS also provided an operating results forecast for 2026, with a forecasted range of net revenues between $18.417 billion and $18.789 billion, representing a 7.1% increase over 2025 net revenues. The forecasted range for adjusted EBITDA net of NCI is between $2.641 billion and $2.789 billion, representing a 4.8% increase over 2025.

The forecasted adjusted EPS-diluted for 2026 is between $22.64 and $24.52 per share, representing an 8.5% increase over the 2025 adjusted EPS-diluted of $21.74. As a result of these announcements, the company's shares have moved -2.11% on the market, and are now trading at a price of $199.88. For the full picture, make sure to review UNIVER's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.